STOCK TITAN

Electromed - ELMD STOCK NEWS

Welcome to our dedicated page for Electromed news (Ticker: ELMD), a resource for investors and traders seeking the latest updates and insights on Electromed stock.

Electromed Inc. (ELMD) specializes in advanced airway clearance solutions through its clinically validated SmartVest system. This dedicated news hub provides investors and healthcare stakeholders with essential updates on respiratory care innovations, regulatory compliance, and corporate developments.

Find authoritative coverage of ELMD's progress in HFCWO technology, including product enhancements, partnership announcements, and quality certifications. Our curated news selection emphasizes factual reporting on clinical trial outcomes and market expansion initiatives within the medical device sector.

Regular updates include earnings disclosures, manufacturing quality milestones, and research collaborations. Bookmark this resource for streamlined access to verified ELMD developments that impact respiratory therapy standards and investment considerations.

Rhea-AI Summary
Electromed, Inc. (ELMD) announced that its President and CEO, Jim Cunniff, and CFO, Brad Nagel, will attend the 2024 Lytham Partners Investor Select Conference on February 1, 2024. The management team will participate in a fireside chat and investor 1x1s, with the fireside chat scheduled for 11 am Eastern Time. Interested parties can register for the fireside chat using the provided link.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.6%
Tags
conferences
-
Rhea-AI Summary
ELMD Electromed Reports 16% Revenue Growth in Q1 FY 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.09%
Tags
-
Rhea-AI Summary
Electromed, Inc. has launched the SmartVest Clearway Airway Clearance System for inpatient use in hospitals. The system uses High Frequency Chest Wall Oscillation therapy to clear excess secretions from the lungs and reduce the risk of respiratory infections. It provides therapeutic relief for patients with ineffective secretion clearance and aims to speed up patient recovery.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.1%
Tags
none
Rhea-AI Summary
Electromed, Inc. announced that its President and CEO, Jim Cunniff, and CFO, Brad Nagel, will attend the Canaccord Genuity MedTech, Diagnostics, and Digital Health & Services Forum on November 16, 2023 in New York City. The management team will engage in investor 1x1s on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.66%
Tags
conferences
-
Rhea-AI Summary
Electromed, Inc. will release its financial results for the fiscal 2024 first quarter on November 7, 2023. A conference call will be held to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Electromed, Inc. announces record annual revenue and Q4 revenue growth of 21%. FY 2023 revenue increased 15% to $48.1 million. Operating income increased 35% to $4.0 million. Net income increased to $3.2 million, or $0.36 per diluted share. Cash as of June 30, 2023, was $7.4 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.57%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.31%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.2%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.9%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.39%
Tags
none
Electromed

NYSE:ELMD

ELMD Rankings

ELMD Stock Data

195.01M
6.82M
20.54%
43.56%
2.44%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
NEW PRAGUE